Industry News

Director of Pharmacovigilance (Medic) – South East

Tuesday, May 21st, 2013

Moin Din is recruiting for an experienced Pharmacovigilance Director (Medic) to join a progressive Pharmaceutical company in the South East of the UK.

Responsibilities:

  • Ensure quality of Serious Adverse Event data by providing medical expertise and judgment throughout the case-handling process with medical review of individual cases and analysis of safety reports.
  • Accountable for the medical review and editing of individual case safety reports. This involves checking, editing where appropriate and reviewing the contents ensuring that the data reflects the original data from the investigator / reporter and ensuring that coding and assessment are correct and in line with regulatory and procedural documents (e.g. SOP) requirements.
  • Accountable for the final medical review of case reports including decisions on SUSARs in a timely fashion and ensuring that all necessary queries have been generated, followed-up and addressed and that relevant data and reports are available.
  • Prepare Line Listing concise summaries and be Primary Author for Development Safety Update Reports (DSURs) for assigned projects.

Education/experience:

  • Medically qualified physician with significant post-registration clinical experience. MRCP or equivalent. GMC registered.
  • Minimum experience level – At least 4 years Clinical Practice experience and at least 5 years in Industry (Pharma, CRO) and significant experience in drug safety.
  • Detailed knowledge of Pharmacovigilance and safety reporting (especially EU, but also awareness of global pharmacovigilance regulatory requirements) and understanding of business impact of Pharmacovigilance function.
  • Experience in the review, analysis and interpretation

    of scientific data and presentation of results in a concise and clear manner to both scientific and non-scientific audiences.

  • Knowledge and experience of implementation of signal detection processes.Moin Din - Senior Recruitment Consultant at CK Clinical

How to apply:

For further detailed information and an informal discussion, please contact Moin Din in the first instance on 0207 470 5675 or email mdin@ckclinical.co.uk. Please quote reference CL24967 in all correspondence.

 

Search our latest pharmaceutical jobs here

Pharmaceutical jobs    pharmaceutical jobs

US venture capitalist appoints industry heavyweights

Thursday, May 16th, 2013

as reported by PMLive.com Venture Capitalist company, Third Rock Ventures

has expanded by hired some of the industries top professionals. Having appointed executives from Lilly, Genzyme, Alnylam and InClone the company, which helps build healthcare companies plans to use the new expertise to translate scientific innovations into new companies.

New Roles

James Geraghty, who has spent 20-years at Genzyme, becomes entrepreneur-in-residence, while

Steven Paul the former president of Lilly Research Laboratories,  takes on an increased role at Third Rock with a position as a venture partner.

Daniel Lynch, former CEO of ImClone Systems and John Maraganore, Alnylam’s CEO are also joining as venture partners.

Business Development

Robert Tepper, partner at Third Rock Ventures, said: “These leaders have demonstrated – through decades of experience – their ability to integrate science and business.

“The depth of their expertise across commercial, business development, R&D, drug discovery and product development will be invaluable to Third Rock as we focus on translating scientific innovation into exceptional companies that make a difference for patients.”

Are you looking for a new job?

Click here to view our current job listings

    Pharmaceutical jobs uk

Our latest pharmaceutical Jobs – 13 May 2013

Monday, May 13th, 2013

Here are our latest pharmaceutical jobs:

 

Pharmaceutical JobsMedic:

PD Clinical Director - South East

 

Biometrics:

Senior Statistical Programmer - UK

UK Regulatory Professional - Buckinghamshire

Global Data Manager - Belgium

 

Clinical Operations:

Clinical Study Manager (Ux) - Home Counties

pharmaceutical jobsOncology CRA, London / Midlands

Clinical Study Manager - Home Counties

Senior Specialist, Clinical Compliance - Cambridge

Senior Manager, Compliance - South East

Administrative Coordinator - Uxbridge

 

Drug Safety:

Regional Medical Liaison - South

East

Medical Information Associate - South East 

Clinical Drug Safety Officer - South East

 

Not quite what you’re looking for?

Click here to register your CV with CK Clinical today.

Online Cancer forum launched by former Google chief

Monday, May 13th, 2013

As reported by PMLive.com Smart Patients, a new online community for cancer patients and caregivers, has just been launched by the former chief health strategist at Google, Dr Roni Zeiger.

Founded by Zeiger and Gilles Frydman, who founded the Association of Cancer Online Resources (ACOR) in 1995, the site aims to encourage members to learn from each other about different forms of treatment, search for clinical trials and the latest science relating to their diagnosis, and to share best practice from a patient perspective.

“Our goal at Smart Patients is to help cancer patients get better care by learning from each other in an online community with social networking and search technology. Many patients with cancer become extraordinarily knowledgeable about their specific disease, and when they get together in a network, the learning that happens is impressive.”  explained Zeiger.

The site already has a number of key partners, including The Bonnie J. Addario Lung Cancer Foundation, the not-for-profit ‘open science

initiative’ Cancer Commons, biotech Oncosec Medical and the digital healthcare marketing agency WorldOne Interactive.

Are you looking for a job in Clinical Trials?

Click here to view our current jobs

Clinical jobs 

Jobs of the Week – 07 May 2013

Tuesday, May 7th, 2013

Here are our pharmaceutical jobs of the week:

 

Clinical jobsRegulatory Affairs:

Senior Manager Regulatory Affairs - Oxfordshire

Regulatory Associate - Oxfordshire

Associate Director, Regulatory Affairs - Hertfordshire

 

Biometrics:

Clinical Programmer - Hertfordshire

Statistical Scientist - Hertfordshire

Clinical Project Manager - London

 Clinical jobs

Clinical Operations:

Clinical Study Manager  – Uxbridge

Contracts & Procurement Assistant - Home Counties

Administrative Coordinator - Uxbridge

 

Pharmacovigilance and Medical Information

Scientific Advisor - Surrey

Drug Safety Specialist - London

Medical Science Liaison - Ireland

 

Search our other pharmaceutical jobs here

Pfizer and Merck & co collaborate to develop a new diabetes treatment.

Thursday, May 2nd, 2013

Pharmatimes has reported that Merck & Co and Pfizer have formed a new alliance to jointly develop and commercialise the latter’s ertugliflozin for the treatment of type II diabetes.

Pfizer’s ertugliflozin is an investigational oral sodium glucose cotransporter (SGLT2) inhibitor  which is being evaluated for the treatment of type 2 diabetes. Ertugliflozin is Phase III ready, with trials commencing soon.

“We are pleased to join forces with Merck in the battle against type 2 diabetes and the burden that it poses on global health,” said John Young, president and general manager, Pfizer Primary Care. “Through this collaboration, we believe we can build on Merck’s leadership position in diabetes care with the introduction of ertugliflozin, an innovative SGLT2 inhibitor discovered by Pfizer scientists.

 

Search our latest pharmaceutical jobs here

pharmaceutical jobs      Pharmaceutical jobs

New London Lung Cancer Alliance announced

Friday, April 26th, 2013

As reported on www.PharmaTimes.com . An new alliance between research institutions in London has been confirmed which aims to conduct trials with up to 3,000 patients a year on personalised therapies for lung cancer.

The London Lung Cancer Alliance is a collaboration between Imperial College London, Imperial College Healthcare NHS Trust, Kings College London, Royal Brompton & Harefield NHS Foundation Trust, The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, St George’s Healthcare NHS Trust and Barts Cancer Institute at Queen Mary, University of London.

They plan to offer as many patients as possible a panel of targeted therapies that match their cancer’s molecular profile. With the primary aim of covering the entire lung cancer pathway from identification and screening through to end-stages of the disease. Researchers within the Alliance will also develop liquid-biopsy blood tests for patients who are too ill to undertake a conventional biopsy, or to monitor whether drugs are working and look for signs of resistance.

The Alliance will  expand its reach by linking up with five other cities across the UK including Newcastle, Southampton, Liverpool, Cardiff and Edinburgh,

To read this article in full click here

Are you interested in a job in Clinical Research?

Click here to view our current Clinical Research jobs

   Clinical Jobs kamagra

Our Latest Pharmaceutical Jobs – 22 April 2013

Monday, April 22nd, 2013

Here are our latest pharmaceutical jobs – 22 April 2013:

 

Pharmaceutical jobsRegulatory Affairs:

Global Regulatory Manager - Switzerland

Labelling Specialist - Hertfordshire

Lead Consultant, Market Access - Anywhere in Europe

Regulatory Officer - Middlesex

 

Clinical Operations:

Clinical Operations Manager - Switzerland

CTS Manager - Barnard Castle

Contract Clinical Scientist, Switzerland 

Principal Specialist – Global Clinical Supplies - Home counties

 Pharmaceutical Recruitment in Europe - CK Clinical

Medical information and Drug Safety

Pharmacovigilance Assistant - Berkshire

Principal Pharmacovigilence Auditor - South East

Medical Information Specialist- South East

 

Biometrics:

Clinical Data Manager  – Greater Manchester

Biostatistician - Paris

SClinical jobsenior Statistical Scientist - South East

 

Medics:

Medical Affairs Manager – Epilepsy-UK/Ir

 

Not quite what you’re looking for?

Click here to register your CV with CK Clinical today.

Vertex Cystic Fibrosis combo provides promising data

Friday, April 19th, 2013

PharmaTimes posted today that shares in Vertex Pharmaceuticals have soared by 54% due to data from their mid-stage trial of the investigational cystic fibrosis drug VX-661, combined with their approved treatment Kalydeco.

Results have shown that when combined, the VX-661 and Kalydeco provide significatant improvement in lung function among adults with CF who also have two copies of the most common mutation in the F508del gene.

The Phase II study have seen significant improvement in patients in the 100 – 150mg combination dose groups, versus placebo, of 9.0% and 7.5%, respectively, at day 28. In contrast, patients who received placebo showed a 0.03% change. 

Peter Mueller, Vertex chief scientific officer, said the study “provides further validation of the strategy of combining a corrector  [VX-661]

and potentiator to improve lung function in people with the most common type of CF. He added that “with these data and the recent initiation of a Phase III programme for a combination of our lead cystic fibrosis transmembrane conductance regulator (CFTR) corrector VX-809 with ivacaftor, we are making significant progress toward our goal to help many more people with CF.”

 

If you are interested in working in clinical trials click here to visit our current vacancies or if you prefer working in drug discovery you can visit our current jobs here

 

Vertex releases promising data from cystic fibrosis drug     Vertex drug improves cystic fibrosis

Pharmaceutical jobs of the week – 15th April 2013

Monday, April 15th, 2013

Here are our jobs of the week in the the UK and Europe:

 

Pharmaceutical jobs of the weekDrug Safety & Medical Information

Principal Pharmacovigilence Auditor -South East of the UK

Medical Information Specialist - Berkshire

 

Biometrics:

Clinical Data Management Manager - Home counties

 

Regulatory Affairs:

Global Regulatory Lead - Surrey

Regulatory Affairs, Emerging Markets - London

Pharmaceutical jobsRegulatory Operations Specialist - Shreeya Patel

Submissions Manager - South East ofthe UK

 

Clinical Operations:

Senior Director – Quality Assurance, GCP / GLP - Homecounties

Expert Clinical Manager  – Switzerland

Trial Start Up Specialist - Switzerland

Principal Global Compliance & Training Specialist - Buckinghamshire

Clinical Project Manager - Cambridgeshire

 

Not quite what you’re looking for?

Click here to register your CV with CK Clinical today.

Once registered, one of our specialist Pharmaceutical Recruitment Consultants will be in contact to discuss your requirements

and any relevant pharmaceutical jobs we are recruiting for at the moment.

viagra

Search for a job

Advanced search

Search Eu

Recruiting different levels of statistical programmers


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

How this site uses cookies
Cookies are small text files that can be used by websites to make a user's experience more efficient. This site does use some non-essential cookies so we are legally obliged to inform visitors of their existence. These cookies do not track individual users or identify them, but are used to gain useful knowledge about how the site is used so that we can keep improving it for our users.

This site uses different types of cookie. We use Google Analytics, a popular web analytics service provided by Google, Inc. Google Analytics uses cookies to help us to analyse how users use the site. It counts the number of visitors and tells us things about their behaviour overall – such as the typical length of stay on the site or the average number of pages a user views.

The information generated by the cookie about your use of our website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of our website, compiling reports on website activity and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google's behalf. Google undertakes not to associate your IP address with any other data held by Google.

If you want to delete any cookies that are already on your computer, please refer to the instructions for your file management software to locate the file or directory that stores cookies. You can access them through some types of browser. More information about cookies, including how to block them or delete them, can be found on the ICO website.

Some third party cookies are set by services that appear on our pages. They are set by the operators of that service and are not in our control. They are set by Twitter, Facebook and Sharethis and relate to the ability of users to share content on this site.

If you have any queries about the use of cookies on this website please contact information@ckscience.co.uk

Close